Internal Medicine, Cardiovascular Disease · Neptune, NJ
NPI
1285604207
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
1820 Corlies Ave, Suite 4b
Neptune, NJ, 07753
Phone (732) 776-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
9,778 services
Medicare patients, 2024
1,766
Average age 78
Drug cost, 2024
$3.3M
13,972 prescriptions
Company payments, 2025
$1,884
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James F Orlando was code 99214 (office e&m - established), 2,296 times for 1,283 patients. In total James F Orlando billed 9,778 services in 78 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,296 | 1,283 | $97.26 | $223K |
| 93000 Electrocardiogram | Office | 1,860 | 1,233 | $11.23 | $21K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,172 | 293 | $5.37 | $6,297 |
| 93306 Echocardiography (TTE/TEE) | Office | 544 | 541 | $164.35 | $89K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 494 | 442 | $13.72 | $6,778 |
| 93040 Electrocardiogram | Office | 423 | 423 | $10.90 | $4,612 |
| 93015 Electrocardiogram | Office | 331 | 330 | $61.41 | $20K |
| 93010 Electrocardiogram | Facility | 318 | 282 | $6.75 | $2,147 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 286 | 282 | $154.59 | $44K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 270 | 269 | $619.19 | $167K |
| 78434 Myocardial Perfusion Scan | Office | 269 | 269 | $502.39 | $135K |
| 78492 Myocardial Perfusion Scan | Office | 269 | 269 | $1,411.61 | $380K |
| 93041 Electrocardiogram | Office | 121 | 121 | $5.62 | $680 |
| 99152 Anesthesia | Facility | 89 | 77 | $10.17 | $905 |
| 99232 Hospital E&M - Subsequent | Facility | 88 | 64 | $66.42 | $5,845 |
By year: 2022 $1.5M for 10,487 services; 2023 $1.2M for 9,562 services; 2024 $1.3M for 9,778 services.
Medicare prescription drug claims, 2024
In 2024, the drug James F Orlando prescribed most often to Medicare patients was Metoprolol Succinate, with 1,489 prescriptions and refills. In total James F Orlando wrote 13,972 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,489 | 4,284 | 462 | $26K |
| Rosuvastatin Calcium Generic | 1,450 | 4,312 | 452 | $24K |
| Atorvastatin Calcium Generic | 1,143 | 3,401 | 349 | $15K |
| Eliquis Apixaban | 703 | 1,708 | 200 | $963K |
| Amlodipine Besylate Generic | 643 | 1,875 | 190 | $5,308 |
| Losartan Potassium Generic | 641 | 1,882 | 184 | $6,744 |
| Clopidogrel Clopidogrel Bisulfate | 454 | 1,315 | 157 | $8,121 |
| Carvedilol Generic | 418 | 1,251 | 124 | $4,769 |
| Xarelto Rivaroxaban | 383 | 935 | 103 | $503K |
| Furosemide Generic | 325 | 907 | 122 | $2,323 |
| Metoprolol Tartrate Generic | 318 | 924 | 114 | $3,233 |
| Valsartan Generic | 316 | 905 | 97 | $12K |
| Repatha Sureclick Evolocumab | 264 | 438 | 50 | $239K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 218 | 613 | 65 | $8,601 |
| Lisinopril Generic | 202 | 568 | 56 | $1,395 |
Brand drugs: - claims; generic drugs: 11,533 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James F Orlando $1,884 ($1,884 in general payments such as food, travel and fees) from 19 companies. The largest payer was Medtronic, Inc. with $339.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 3 | $339 |
| Novartis Pharmaceuticals Corporation NVS | 45 | $307 |
| Abbott Laboratories ABT | 10 | $297 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $268 |
| Novo Nordisk Inc NVO | 19 | $189 |
| Boston Scientific Corporation BSX | 3 | $64.62 |
| CVRx, Inc. CVRX | 3 | $56.06 |
| Tactile Systems Technology Inc TCMD | 2 | $53.82 |
| Pfizer Inc. PFE | 3 | $51.21 |
| BridgeBio Pharma, Inc. BBIO | 3 | $43.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.